Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in NERV — Minerva Neurosciences, Inc.

CIK 70858 CHARLOTTE, NC
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$209,412
-$31,407 QoQ
Shares Held
37,732
-5.6% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 58 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. NERV ranks #287 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in NERV

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $209,412 37,732
2026-03-31 $240,819 39,970
2025-12-31 $204 51
2025-09-30 $104 50
2025-06-30 $90 53
2025-03-31 $78 46
2024-12-31 $99 45
2024-09-30 $152 57
2024-06-30 $538 169
2024-03-31 $322 125
2023-12-31 $786 128
2022-12-31 $9 6
2022-03-31 $118 144
2021-12-31 $665 832
2021-09-30 $14,303 8,221
2021-06-30 $99,515 42,895
2021-03-31 $105,545 36,146
2020-12-31 $48,465 20,712
2020-09-30 $44,188 13,896
2020-06-30 $66,210 18,341
2020-03-31 $132,541 22,017